Comparative study of analgesic effectiveness using three different anesthetic techniques for intravitreal injection of bevacizumab

Ophthalmic Surgery Lasers and Imaging

Volumn 40, Issue 1, 2009, Pages 13-18

  Cintra, Léssia P ^a   Lucena, Levy R ^a   Da Silva, José A ^a   Costa, Rogério A ^a,b   Scott, Ingrid U ^c   Jorge, Rodrigo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Hospital de Olhos de Araraquara   (Brazil)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTALCON; BEVACIZUMAB; LIDOCAINE; PROXYMETACAINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANALGESIA; ANESTHESIA; ARTICLE; COMPARATIVE STUDY; CONJUNCTIVAL HEMORRHAGE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DRUG EFFICACY; FEMALE; HUMAN; INJECTION PAIN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION;

ANALGESIA; ANESTHESIA, LOCAL; ANESTHETICS, LOCAL; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; INJECTIONS; LIDOCAINE; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PROPOXYCAINE; VITREOUS BODY;

EID: 59449096566     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/15428877-20090101-05     Document Type: Article

References (23)

1. Taskintuna I, Rahhal FM, Arevalo JF, et al. Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology. 1997;104:1049-1057.
2. Scott IU, Cruz-Villegas V, Flynn HW Jr, Miller D. Delayed-onset, bleb-associated endophthalmitis caused by Lecythophora mutabilis. Am J Ophthalmol. 2004;137:583-585.
3. Bonini-Filho MA, Jorge R, Barbosa JC, Calucci D, Cardillo JA, Costa RA. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial. Invest Ophthalmol Vis Sci. 2005;46:3845-3849.
4. Gragoudas ES, Adamis AP, Cunningham ET Jr, et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med. 2004;351:2805-2816.
5. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419-1431.
6. Luke M, Warga M, Ziemssen F, et al. Effects of bevacizumab on retinal function in isolated vertebrate retina. Br J Ophthalmol. 2006;90:1178-1182.
7. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2005;36:133-135.
8. Costa RA, Jorge R, Calucci D, Cardillo JA, Melo LA, Scott IU. Intravitreal bevacizumab (Avastin) for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase I dose-escalation study. Invest Ophthalmol Vis Sci. 2006;47:4569-4578.
9. Avery RL. Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina. 2006;26:352-354.
10. Silva Paula J, Jorge R, Costa RA, Rodrigues ML, Scott IU. Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma. Acta Ophthalmol Scand. 2006;84:556-557.
11. Jorge R, Costa RA, Calucci D, Cintra LP, Scott IU. Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBePe Study). Retina. 2006;26:1006-1013.
12. Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina. 2006;26:275-278.
13. Friedman SM, Margo CE. Topical gel vs subconjunctival lidocaine for intravitreous injection: a randomized clinical trial. Am J Ophthalmol. 2006;142:887-888.
14. Kozak I, Cheng L, Freeman WR. Lidocaine gel anesthesia for intravitreal drug administration. Retina. 2005;25:994-998.
15. Kishore K, Conway MD, Peyman GA. Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis. Ophthalmic Surg Lasers. 2001;32:183-192.
16. Kaderli B, Avci R. Comparison of topical and subconjunctival anesthesia in intravitreal injection administrations. Eur J Ophthalmol. 2006;16:718-721.
17. Huskisson EC. Visual analogue scales. In: Melzak R, ed. Pain Measurement and Assessment. New York: Raven Press; 1983:33-37.
18. Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983;17:45-56.
19. Price DD, Bush FM, Long S, Harkins SW. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain. 1994;56:217-226.
20. Rosier EM, Iadarola MJ, Coghill RC. Reproducibility of pain measurement and pain perception. Pain. 2002;98:205-216.
21. Kanai A, Hoka S. A comparison of epidural blockade produced by plain 1% lidocaine and 1% lidocaine prepared by dilution of 2% lidocaine with the same volume of saline. Anesth Analg. 2006;102:1851-1855.
22. Da Silva JA. Avaliação e mensuração de dor: pesquisa, teoria e prática. In: Ribeiro Filho NP, ed. Mensuração Psicofísica de Atributos Hedônico e Cognitivos da Sensação de Dor. Ribeirão Preto, São Paulo, Brazil: FUN-PECRP-Editora (Francisco Moura Duarte); 2006:279-325.
23. Edge R, Navon S. Scleral perforation during retrobulbar and peribulbar anesthesia: risk factors and outcome in 50,000 consecutive injections. J Cataract Refract Surg. 1999;25:1237-1244.